QuarterWatch analyzes MedWatch Reports

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.

To read this article, please click here.

Posted in

More RSI News

RSI wins 2019 Consulting Engineers of Ontario Award of Merit

June 14, 2019
RSI logo in white

Risk Sciences International (RSI), as members of a consulting team with Stantec, along with the Ontario First Nations Technical Services Corporation (OFNTSC), has won an Award of Merit from the…

Read News Item

Updated CSA Technical Guide for Infrastructure in Permafrost published

June 4, 2019
RSI logo in white

A second updated edition of the CSA national permafrost standard was published on May 21, 2019 and features climate and climate change information provided by…

Read News Item

RSI chairs panel session at Building the Next Generation of Canadian Infrastructure Conference

May 15, 2019
RSI logo in white

RSI chairs and presents on panel sessions for the Toronto conference, “Building the Next Generation of Canadian Infrastructure: Defining a roadmap for optimizing infrastructure planning,…

Read News Item

RSI Chairs Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA)

March 28, 2019
RSI logo in white

RSI’s Dr. Emma Hartnett chaired the recent Joint FAO/WHO Expert Meeting on Microbiological Risk Assessment (JEMRA). The focus of the week-long event held March 11…

Read News Item